CME

CME


Latest Episodes

Limitations of the Current Therapeutics Used to Manage CIAS
April 30, 2024

Host: Philip D. Harvey, PhD Guest: Martin Strassnig, MD This series of bite-sized episodes will provide important information on cognitive impairment associated with schizophrenia. Drs. Philip Harvey and Martin Strassnig discuss the pathophy

Understanding CIAS: What Does Current Literature Say About the Etiology and Pathophysiology of CIAS?
April 30, 2024

Host: Martin Strassnig, MD Guest: Philip D. Harvey, PhD This series of bite-sized episodes will provide important information on cognitive impairment associated with schizophrenia. Drs. Philip Harvey and Martin Strassnig discuss the pathophy

Integration Is the Key to Success: How Will the New SCZ Therapies Fit Into Clinical Treatment Paradigms?
April 30, 2024

Host: Philip D. Harvey, PhD Guest: Martin Strassnig, MD This series of bite-sized episodes will provide important information on cognitive impairment associated with schizophrenia. Drs. Philip Harvey and Martin Strassnig discuss the pathophy

Not All Therapy Needs to Be Swallowed or Injected: The Future of Digital Therapeutics to Alleviate the Negative Symptoms of Schizophrenia
April 30, 2024

Host: Martin Strassnig, MD Guest: Philip D. Harvey, PhD This series of bite-sized episodes will provide important information on cognitive impairment associated with schizophrenia. Drs. Philip Harvey and Martin Strassnig discuss the pathophy

ACC 2024: The PIONEER AF-PCI Trial
April 30, 2024

Host: Manesh R. Patel, MD This program brings you select scientific abstracts and late-breaking results from the recent American College of Cardiology 2024 Scientific Sessions. From clinical trials like PIONEER-AF and VOYAGER PAD to updates on t

ACC 2024: What's Really New in Electrophysiology That Will Change My Practice?
April 30, 2024

Host: Manesh R. Patel, MD This program brings you select scientific abstracts and late-breaking results from the recent American College of Cardiology 2024 Scientific Sessions. From clinical trials like PIONEER-AF and VOYAGER PAD to updates on t

ACC 2024: VOYAGER PAD Part 1
April 30, 2024

Host: Marc P. Bonaca, MD, MPH This program brings you select scientific abstracts and late-breaking results from the recent American College of Cardiology 2024 Scientific Sessions. From clinical trials like PIONEER-AF and VOYAGER PAD to updates

ACC 2024: VOYAGER PAD Part 2
April 30, 2024

Host: Marc P. Bonaca, MD, MPH This program brings you select scientific abstracts and late-breaking results from the recent American College of Cardiology 2024 Scientific Sessions. From clinical trials like PIONEER-AF and VOYAGER PAD to updates

ACC 2024: SHASTA-2 Final Study Results
April 30, 2024

Host: Daniel Gaudet, MD, PhD This program brings you select scientific abstracts and late-breaking results from the recent American College of Cardiology 2024 Scientific Sessions. From clinical trials like PIONEER-AF and VOYAGER PAD to updates o

Making the Case for Dual Ang-2/VEGF-A Inhibition: Anatomical Benefits
April 30, 2024

Host: Jennifer I. Lim, MD, FARVO Guest: Carl Regillo, MD What evidence do we have that blocking Ang-2 and VEGF-A is beneficial for patients? Tune in to hear Dr. Jennifer Lim and Dr. Carl Regillo examine the anatomical and biomarker evidence